Lung Cancers Completed Phase 1 / 2 Trials for Bexarotene (DB00307)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00238628A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung CancerTreatment